Medicine

• The author argues that modern medical science has shifted from seeking truth to protecting a "medical monopoly," leading to the suppression of effective therapies like chlorine dioxide. • The text criticizes the reliance on expensive randomized controlled trials (RCTs), claiming they are often manipulated by sponsors to artificially inflate the safety and efficacy of drugs. • This systemic issue matters because it prioritizes corporate profit over human health, rendering high-cost data worthless when it serves prevailing interests rather than clinical truth.

• HCA Healthcare has announced a new study published in the New England Journal of Medicine (NEJM) highlighting advancements in CRISPR-based therapies for children. • The research builds upon pioneering work at TriStar Centennial Medical Center and the Sarah Cannon Transplant and Cellular Therapy Network, which performs over 1,600 cellular therapies and transplants annually. • Dr. Frangoul, a key investigator, previously contributed to the first U.S. clinical trial for gene-editing in sickle cell disease, leading to the first FDA-approved CRISPR therapy.

• The US Administration is restructuring the systems supporting PEPFAR and global health security, shifting its engagement strategy toward regulatory influence over long-term public health partnerships. • Concerns are rising that increased political oversight and the deconstruction of international collaborations may undermine the NIH's scientific infrastructure and its history of HIV research and vaccine development. • In a move toward regulatory cooperation, the US Food and Drug Administration (FDA) and the African Medicines Agency (AMA) signed a Memorandum of Understanding (MoU) to establish a shared framework for information sharing.

• UC San Diego engineers are researching the ability to grow plants under simulated space conditions to produce essential pharmaceuticals during long-term missions. • The initiative addresses a critical safety gap, as medications degrade faster in space; studies show over half of the International Space Station's drug supply expires within three years. • This biological production method is vital for deep-space travel, such as a round trip to Mars, which requires approximately 400 days of travel time.

• The Vanderbilt Report's weekly briefing for June 1–8, 2026, highlights several major medical breakthroughs, including new findings regarding GLP-1 weight-loss drugs. • Key developments include the discovery of a "striking new cancer signal" associated with GLP-1 medications and the emergence of a one-shot gene editing infusion. • These advancements are significant as they potentially expand the therapeutic use of weight-loss drugs and simplify the delivery of genetic treatments.

• New research on mice suggests that a common anti-aging drug combination may cause brain damage, specifically severe myelin loss and symptoms similar to "chemo brain." • A review of 17 studies indicates that guava juice can significantly improve anemia in women and teenage girls by enhancing the body's iron absorption. • These findings highlight critical risks associated with longevity treatments and offer a dietary alternative for managing iron deficiency.

• Researchers are testing a novel approach to treating depression by using anti-inflammatory drugs to calm the immune system rather than targeting brain chemicals. • In a small clinical trial conducted around May 28, 2026, early results indicate that reducing systemic inflammation may alleviate depressive symptoms. • This discovery is significant because it suggests a biological link between the immune system and mental health, potentially offering an alternative for patients who do not respond to traditional antidepressants.